A cheeky website about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. If you have a tip or want to discuss a story please feel free to email Betaville at ben@betaville.co.uk. Betaville can also be reached at Whats App, Signal or Telegram. Betaville's Twitter handle is @bharringtonw11 and you can message me via Twitter with stories.

Top of the market? - part 6

Wednesday, 10 February 2016, 12:54 am

I know I should probably reign in the chest beating but global stock markets are down almost 20pc since last spring's highs, so perhaps my "top of the market" series was useful to readers after all...

Read more...

Dobson to retire from FTSE 100-listed Schroders, according to The Times

Tuesday, 9 February 2016, 5:41 pm

It never ceases to amazes me how some of the juiciest City tales end up in the diary.

For example, the lead item in The Times City People diary reveals there is a "whisper" Michael Dobson, the veteran Schroders chief executive, is contemplating retirement and may to step down from the blue-chip, blue-blooded fund manager at the next set of figures.

Here is a link to the column:..

Read more...

HSBC takeaway - part 2

Friday, 5 February 2016, 1:20 am

Readers might recall that earlier this week HSBC was quick out of the blocks to boast how it was the "sole" financial advisor to ChemChina on its $43 billion purchase of Sygenta, sending out a release on topic in the early hours of Wednesday morning...

Read more...

HSBC takeaway

Wednesday, 3 February 2016, 9:33 am

Ping! An email arrives from HSBC with the headline:

HSBC sole financial advisor to ChemChina on Syngenta acquisition

That's before I had even received the formal $43 billion deal announcement from Syngenta or ChemChina...

Read more...

Burmese Business - part 4

Friday, 29 January 2016, 1:53 am

It still never ceases to amaze me how quickly stocks fall in and out of fashion with investors, traders and market participants.

Indeed, the healthcare/ biotech sector has taken another serious pasting today following worse-than-expected figures from Roche, the Swiss pharmaceutical giant. So, AstraZeneca is down 3pc today while Shire has fallen almost 5pc.

However, there is one stock that has quiet literally reversed a rout of its share price: MySQUAR...

Read more...

Irritating

Thursday, 28 January 2016, 10:08 pm

If there is one thing that really irritates me it's being beaten to the punch by rival hacks on a story I had spent several days trying to stand up.

Yes, that does occasionally happen to me.

And yesterday was particularly galling as I was just about publish a piece about how the Novum takeover had run into difficulties when hacks and hackettes at the Financial Times released their version of the jackanory. Here is a link to their piece:..

Read more...

Shell/BG Group worries - part 5

Thursday, 28 January 2016, 4:39 am

I see Royal Dutch Shell's £35 billion purchase of BG Group has been approved by over 80pc of the  Anglo Dutch company's shareholders.

So I guess the Telegraph's recent scaremongering about the deal collapsing, led by Jupiter fund manager Ian McVeigh, was just, err, scaremongering......

Read more...

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].